Tofacitinib, an Oral Janus Kinase Inhibitor: Pooled Efficacy and Safety Analyses in an Australian Rheumatoid Arthritis Population

INTRODUCTION: In Australia, there is an unmet need for improved treatments for rheumatoid arthritis (RA). Tofacitinib is an oral Janus kinase inhibitor for the treatment of RA. To provide an overview of key study outcomes for tofacitinib in Australian patients, we analyzed the efficacy and safety of...

Descripción completa

Detalles Bibliográficos
Autores principales: Hall, Stephen, Nash, Peter, Rischmueller, Maureen, Bossingham, David, Bird, Paul, Cook, Nicola, Witcombe, David, Soma, Koshika, Kwok, Kenneth, Thirunavukkarasu, Krishan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251845/
https://www.ncbi.nlm.nih.gov/pubmed/29949132
http://dx.doi.org/10.1007/s40744-018-0118-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251845/
https://www.ncbi.nlm.nih.gov/pubmed/29949132
http://dx.doi.org/10.1007/s40744-018-0118-2

Ejemplares similares